Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHODH | Q02127 | 3/20 | 0.43 |
| ▸ | MALT1 | Q9UDY8 | 3/20 | 0.34 |
| ▸ | NTRK1 | P04629 | 4/20 | 0.31 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MTOR | P42345 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyantraniliprole SCHEMBL29354965 | 0.92 | DHODH (0.42) | DHODHMALT1KMT2ARIPK1 | |
| Cyantraniliprole SCHEMBL166640 | 0.92 | DHODH (0.42) | DHODHMALT1KMT2ARIPK1 | |
| Chlorantraniliprole SCHEMBL29363261 | 0.90 | DHODH (0.44) | DHODHMALT1NTRK1NPC1RAB9A | |
| SCHEMBL30058805 | 0.90 | DHODH (0.44) | DHODHMALT1NTRK1GRM4MEN1 | |
| SCHEMBL678528 | 0.90 | DHODH (0.44) | DHODHMALT1NTRK1GRM4RIPK1 | |
| SCHEMBL782370 | 0.90 | DHODH (0.44) | DHODHMALT1NTRK1GRM4MEN1 | |
| Chlorantraniliprole SCHEMBL29551 | 0.90 | DHODH (0.44) | DHODHMALT1NTRK1NPC1RAB9A | |
| SCHEMBL24576222 | 0.89 | DHODH (0.44) | DHODHMALT1NTRK1GRM4 | |
| SCHEMBL13287802 | 0.89 | DHODH (0.43) | DHODHMALT1NTRK1GRM4 | |
| SCHEMBL10028767 | 0.89 | DHODH (0.45) | DHODHMALT1NTRK1GRM4MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140087946-A1 | Selective Insecticides Based on Anthranilic Acid Diamides and Safeners | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-03-27 | — | — | US | disclosed |
| US-20110059991-A1 | Selective Insecticides Based on Anthranilic Acid Diamides and Safeners | BAYER CROPSCIENCE AG (DE) | 2011-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140087946-A1 | Selective Insecticides Based on Anthranilic Acid Diamides and Safeners | DDC, DDT, AADAC | DHODH 347/4885MALT1 4492/4885NTRK1 3658/4885 |
| US-20110059991-A1 | Selective Insecticides Based on Anthranilic Acid Diamides and Safeners | DDC, DDT, AADAC | DHODH 347/4885MALT1 4492/4885NTRK1 3658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.